• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags KRAS G12D inhibitor

KRAS G12D inhibitor News

Business

Bayer and Kumquat Biosciences Forge Historic Partnership to Pioneer Revolutionary Cancer Treatment

Ryan Peterson 12 Aug, 2025

Bayer AG and Kumquat Biosciences Inc. have announced a collaboration to develop a new cancer drug, focusing on a KRAS G12D inhibitor. The partnership could see Kumquat receiving up...

Popular News

  • Market

    Gold Hits Record High at $2,892 Amid New U.S. Tariffs Announcement

    11 Feb, 2025
  • Business

    Rivian Surges 5.5% After Exceeding Q4 Delivery Expectations

    03 Jan, 2025
  • Business

    Nvidia Shatters Expectations with a Staggering $39.3 Billion Q4 Revenue

    27 Feb, 2025
  • Business

    Milky Mist Dairy Foods Announces Groundbreaking Rs 2,035 Crore IPO to Expand Premium Dairy Portfolio

    22 Jul, 2025
  • Market

    US Markets Edge Higher in Premarket Amid Rising Tariff Tensions with Key Trade Partners

    04 Mar, 2025
  • Economy

    Switzerland's Unemployment Rate Holds Steady at 2.8% in April, Youth Unemployment Sees Slight Decline

    06 May, 2025
  • Business

    Rocket Companies Set to Revolutionize Real Estate with $1.75B Redfin Acquisition

    10 Mar, 2025
  • Market

    Asian Markets Mostly Down Following Japan's Industrial Production Report

    13 Dec, 2024

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.